Mitoxantrone targets the ATP-binding site of FAK, binds the FAK kinase domain and decreases FAK, Pyk-2, c-Src, and IGF-1R in vitro kinase activities.
暂无分享,去创建一个
A. Magis | V. Golubovskaya | W. Cance | D. Ostrov | Mingzhong Zheng | B. Ho
[1] Ann Y Park,et al. Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic development , 2010, The Journal of cell biology.
[2] G. Mcmahon,et al. PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments , 2010, Cancer biology & therapy.
[3] V. Golubovskaya,et al. Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines , 2009, Molecular carcinogenesis.
[4] A. Magis,et al. A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer , 2009, Cell cycle.
[5] A. Magis,et al. A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth. , 2008, Journal of medicinal chemistry.
[6] Matthew D. Wessel,et al. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. , 2008, Cancer research.
[7] V. Golubovskaya,et al. TAE226‐Induced apoptosis in breast cancer cells with overexpressed Src or EGFR , 2008, Molecular carcinogenesis.
[8] Liz Y. Han,et al. Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. , 2007, Cancer research.
[9] Xinming Cai,et al. Structural Basis for the Autoinhibition of Focal Adhesion Kinase , 2007, Cell.
[10] Christopher Autry,et al. Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor* , 2007, Journal of Biological Chemistry.
[11] W. Yung,et al. Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo , 2007, Molecular Cancer Therapeutics.
[12] V. Golubovskaya,et al. Focal adhesion kinase and p53 signaling in cancer cells. , 2007, International review of cytology.
[13] Bob van de Water,et al. Focal adhesion kinase: a potential target in cancer therapy. , 2007, Biochemical pharmacology.
[14] Neil O. Carragher,et al. The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.
[15] Xianyue Ma,et al. Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of Jak2 tyrosine kinase autophophorylation , 2005 .
[16] Xianyue Ma,et al. Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation]. , 2005, Journal of medicinal chemistry.
[17] Y. L. Chen,et al. [Focal adhesion kinase]. , 1999, Sheng li ke xue jin zhan [Progress in physiology].
[18] D. Schlaepfer,et al. Signaling through focal adhesion kinase. , 1999, Progress in biophysics and molecular biology.
[19] S. J. Taylor,et al. Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. , 1994, Molecular biology of the cell.
[20] J. Parsons,et al. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src , 1994, Molecular and cellular biology.
[21] J. Parsons,et al. Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK , 1994, Molecular and cellular biology.
[22] J. Parsons,et al. Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions , 1993, The Journal of cell biology.